2-Chloro-3-fluoro-4-iodopyridine | CAS:148639-07-0

We serve 2-Chloro-3-fluoro-4-iodopyridine CAS:148639-07-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Chloro-3-fluoro-4-iodopyridine

Chemical Name:   2-Chloro-3-fluoro-4-iodopyridine
CAS.NO: 148639-07-0
Synonyms:2-Chloro-3-Fluoro-4-Iodopyridine;
2-Chloro-3-fluoro-6-picoline;
Molecular Formula: C5H2ClFIN
Molecular Weight: 257.43200
 
Physical and Chemical Properties:
Density: 2.1±0.1 g/cm3
Melting point: /
Boiling point: 246.1±35.0 °C at 760 mmHg
Flash point: 102.6±25.9 °C
Index of Refraction: 1.614
 
Specification:
Appearance:Yellow liquid
Purity:≥98.0%
 
Packing:25 KGS/Drum
Storage:Store in a tightly closed container. Store in a cool, dry
Application:   used in the Pharmaceutical intermediate



Contact us for information like 2-Chloro-3-fluoro-4-iodopyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Chloro-3-fluoro-6-picoline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Chloro-3-Fluoro-4-Iodopyridine Use and application,2-Chloro-3-fluoro-6-picoline technical grade,usp/ep/jp grade.


Related News: The safety and effectiveness of TCM is still debated in China, where it has both adherents and skeptics.3-(4-Chlorobutyl)-1H-indole-5-carbonitrile manufacturer Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis.ADENOSINE5'-MONOPHOSPHATESODIUMSALT supplier The first is the API – which is the central ingredient.5-Amino-2-methylbenzenesulfonamide vendor Britons being brought from Wuhan to the UK are being placed in quarantine at Arrowe Park Hospital in the Wirral, northwest England, Raab said.Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high.